Short Interest in Applied DNA Sciences Inc (NASDAQ:APDN) Increases By 42.7%

Applied DNA Sciences Inc (NASDAQ:APDN) saw a large increase in short interest in July. As of July 31st, there was short interest totaling 70,200 shares, anincreaseof42.7% from the July 15th total of 49,200 shares. Based on an average trading volume of 139,700 shares, the short-interest ratio is presently 0.5 days. Approximately13.7% of the shares of the stock are short sold. Approximately13.7% of the shares of the stock are short sold. Based on an average trading volume of 139,700 shares, the short-interest ratio is presently 0.5 days.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Applied DNA Sciences from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd.

Applied DNA Sciences Trading Up 0.8%

Shares of NASDAQ APDN opened at $3.94 on Tuesday. Applied DNA Sciences has a 12-month low of $3.84 and a 12-month high of $2,655.00. The stock has a market cap of $1.71 million, a PE ratio of 0.00 and a beta of -0.02. The company has a 50-day moving average of $4.77 and a 200 day moving average of $31.40.

Applied DNA Sciences (NASDAQ:APDN) last posted its quarterly earnings results on Thursday, August 14th. The technology company reported ($34.00) earnings per share for the quarter, beating the consensus estimate of ($37.50) by $3.50. Applied DNA Sciences had a negative net margin of 399.91% and a negative return on equity of 124.61%. The business had revenue of $0.30 million during the quarter, compared to analysts’ expectations of $1.28 million. On average, sell-side analysts forecast that Applied DNA Sciences will post -0.87 EPS for the current fiscal year.

Institutional Trading of Applied DNA Sciences

Hedge funds have recently made changes to their positions in the company. Millennium Management LLC purchased a new stake in shares of Applied DNA Sciences in the 4th quarter valued at approximately $28,000. Connective Capital Management LLC purchased a new stake in shares of Applied DNA Sciences in the 4th quarter valued at approximately $36,000. Anson Funds Management LP purchased a new stake in shares of Applied DNA Sciences in the 1st quarter valued at approximately $349,000. Finally, Geode Capital Management LLC grew its stake in shares of Applied DNA Sciences by 291.1% in the 4th quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company’s stock valued at $85,000 after buying an additional 310,749 shares during the period. Hedge funds and other institutional investors own 22.22% of the company’s stock.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.